Massachusetts Financial Services CO G1 Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$10.16 - $16.17 $400,314 - $637,114	-39,401 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$13.16 - $22.47 $6,803 - $11,616	-517 Reduced 1.3%	39,401 $529,000
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $6,692 - $9,001	342 Added 0.86%	39,918 $876,000
Q1 2021 May 13, 2021	SELL	$17.58 - $32.59 $269,536 - $499,669	-15,332 Reduced 27.92%	39,576 $952,000
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $6,044 - $11,220	-550 Reduced 0.99%	54,908 $988,000
Q3 2020 Nov 12, 2020	BUY	$11.55 - $23.75 $640,539 - $1.32 Million	55,458 New	55,458 $641,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.